USANA Health Sciences, Inc. (NYSE:USNA) Short Interest Update

USANA Health Sciences, Inc. (NYSE:USNA) was the target of a significant growth in short interest in the month of January. As of January 31st, there was short interest totalling 578,100 shares, a growth of 19.0% from the January 15th total of 485,900 shares. Approximately 5.2% of the shares of the stock are sold short. Based on an average daily volume of 113,600 shares, the days-to-cover ratio is presently 5.1 days.

Hedge Funds Weigh In On USANA Health Sciences

A number of large investors have recently modified their holdings of the company. R Squared Ltd acquired a new position in USANA Health Sciences during the fourth quarter worth $28,000. Safe Harbor Fiduciary LLC acquired a new position in USANA Health Sciences during the 3rd quarter valued at about $30,000. KBC Group NV lifted its holdings in shares of USANA Health Sciences by 96.6% in the third quarter. KBC Group NV now owns 1,056 shares of the company’s stock valued at $40,000 after purchasing an additional 519 shares in the last quarter. KLP Kapitalforvaltning AS purchased a new stake in USANA Health Sciences in the 4th quarter valued at $83,000. Finally, Quantbot Technologies LP bought a new stake in shares of USANA Health Sciences in the 4th quarter worth $132,000. 54.25% of the stock is currently owned by institutional investors.

USANA Health Sciences Trading Up 0.4 %

USNA stock traded up $0.13 during trading on Monday, reaching $31.73. 134,987 shares of the stock were exchanged, compared to its average volume of 123,145. The firm’s 50 day moving average is $34.42 and its 200 day moving average is $37.06. The firm has a market cap of $604.74 million, a P/E ratio of 11.21, a price-to-earnings-growth ratio of 0.84 and a beta of 0.87. USANA Health Sciences has a twelve month low of $30.13 and a twelve month high of $50.49.

Analysts Set New Price Targets

Several analysts recently weighed in on the company. StockNews.com downgraded USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research report on Friday. DA Davidson lifted their target price on USANA Health Sciences from $35.00 to $38.00 and gave the stock a “neutral” rating in a report on Thursday, January 2nd.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.